Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1966 1
1967 1
1970 2
1971 1
1972 5
1973 7
1974 3
1975 4
1976 3
1977 6
1978 5
1979 7
1980 4
1981 9
1982 8
1983 6
1984 10
1985 10
1986 11
1987 18
1988 17
1989 18
1990 19
1991 18
1992 20
1993 32
1994 32
1995 38
1996 34
1997 31
1998 33
1999 48
2000 32
2001 43
2002 42
2003 40
2004 53
2005 59
2006 52
2007 76
2008 82
2009 64
2010 80
2011 94
2012 88
2013 102
2014 107
2015 105
2016 105
2017 100
2018 111
2019 112
2020 107
2021 98
2022 103
2023 93
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

2,186 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Extrahepatic Bile Duct Undifferentiated Carcinoma"
Page 1
Intrahepatic Cholangiocarcinoma.
El-Diwany R, Pawlik TM, Ejaz A. El-Diwany R, et al. Surg Oncol Clin N Am. 2019 Oct;28(4):587-599. doi: 10.1016/j.soc.2019.06.002. Surg Oncol Clin N Am. 2019. PMID: 31472907 Review.
Intrahepatic cholangiocarcinoma (ICC) arises from the epithelial cells of the intrahepatic and extrahepatic bile ducts and occurs proximal to the segmental biliary ducts. ...
Intrahepatic cholangiocarcinoma (ICC) arises from the epithelial cells of the intrahepatic and extrahepatic bile ducts
Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
Elvevi A, Laffusa A, Scaravaglio M, Rossi RE, Longarini R, Stagno AM, Cristoferi L, Ciaccio A, Cortinovis DL, Invernizzi P, Massironi S. Elvevi A, et al. Ann Hepatol. 2022 Sep-Oct;27(5):100737. doi: 10.1016/j.aohep.2022.100737. Epub 2022 Jul 7. Ann Hepatol. 2022. PMID: 35809836 Free article. Review.
Cholangiocarcinoma (CCA) is a heterogeneous group of neoplasms of the bile ducts and represents the second most common hepatic cancer after hepatocellular carcinoma; it is sub-classified as intrahepatic cholangiocarcinoma (iCCA) and extrahepatic cholan …
Cholangiocarcinoma (CCA) is a heterogeneous group of neoplasms of the bile ducts and represents the second most common hepatic …
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Clements O, et al. J Hepatol. 2020 Jan;72(1):95-103. doi: 10.1016/j.jhep.2019.09.007. Epub 2019 Sep 16. J Hepatol. 2020. PMID: 31536748
LAY SUMMARY: Cholangiocarcinoma (CCA) is a cancer arising in the bile ducts inside (intrahepatic CCA) and connected to the liver (extrahepatic CCA). ...In this study, we found that the strongest risk factors for both intrahepatic and extrahepatic CCA a …
LAY SUMMARY: Cholangiocarcinoma (CCA) is a cancer arising in the bile ducts inside (intrahepatic CCA) and connected to the liv …
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag HB, La Vecchia C, Negri E. Bertuccio P, et al. J Hepatol. 2019 Jul;71(1):104-114. doi: 10.1016/j.jhep.2019.03.013. Epub 2019 Mar 23. J Hepatol. 2019. PMID: 30910538 Free article.
BACKGROUND & AIMS: Intrahepatic (ICC) and extrahepatic cholangiocarcinoma (ECC) have rarely been studied individually, probably due to difficulties in their diagnosis and certification. ...LAY SUMMARY: Biliary tract cancers include intrahepatic cholangiocarcinoma (ICC) …
BACKGROUND & AIMS: Intrahepatic (ICC) and extrahepatic cholangiocarcinoma (ECC) have rarely been studied individually, probably d …
New epidemiologic trends in cholangiocarcinoma.
Pascale A, Rosmorduc O, Duclos-Vallée JC. Pascale A, et al. Clin Res Hepatol Gastroenterol. 2023 Nov;47(9):102223. doi: 10.1016/j.clinre.2023.102223. Epub 2023 Oct 4. Clin Res Hepatol Gastroenterol. 2023. PMID: 37797807 Review.
Cholangiocarcinoma (CCA) is the most common biliary tract malignancy and the second most frequent primary hepatic malignancy after hepatocellular carcinoma. During the past three decades, the incidence of intrahepatic cholangiocarcinoma (iCCA) has risen in Western Europe, …
Cholangiocarcinoma (CCA) is the most common biliary tract malignancy and the second most frequent primary hepatic malignancy after hepatocel …
Surveillance in cholangiocellular carcinoma.
Wirth TC, Vogel A. Wirth TC, et al. Best Pract Res Clin Gastroenterol. 2016 Dec;30(6):987-999. doi: 10.1016/j.bpg.2016.11.001. Epub 2016 Nov 14. Best Pract Res Clin Gastroenterol. 2016. PMID: 27938792 Review.
Cholangiocellular carcinoma is the most frequent malignant neoplasm originating from the epithelium of intra- or extrahepatic bile ducts. ...
Cholangiocellular carcinoma is the most frequent malignant neoplasm originating from the epithelium of intra- or extrahepatic
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma.
Mattiucci GC, Autorino R, D'Agostino GR, Deodato F, Macchia G, Perri V, Tringali A, Morganti AG, Mutignani M, Valentini V. Mattiucci GC, et al. Crit Rev Oncol Hematol. 2014 Apr;90(1):58-67. doi: 10.1016/j.critrevonc.2013.10.007. Epub 2013 Nov 2. Crit Rev Oncol Hematol. 2014. PMID: 24289902 Review.
BACKGROUND: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if and when radiotherapy could be effective for this group of patients. ...RESULTS: There are no randomized trials regarding the treatment of …
BACKGROUND: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if an …
Cholangiocarcinoma: Diagnosis and Management.
Buckholz AP, Brown RS Jr. Buckholz AP, et al. Clin Liver Dis. 2020 Aug;24(3):421-436. doi: 10.1016/j.cld.2020.04.005. Epub 2020 May 29. Clin Liver Dis. 2020. PMID: 32620281 Review.
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Esnaola NF, et al. Cancer. 2016 May 1;122(9):1349-69. doi: 10.1002/cncr.29692. Epub 2016 Jan 22. Cancer. 2016. PMID: 26799932 Free article. Review.
Cholangiocarcinomas are generally categorized as intrahepatic or extrahepatic depending on their anatomic location. The majority of patients with cholangiocarcinoma do not have any of the known or suspected risk factors and present with advanced disease. ...
Cholangiocarcinomas are generally categorized as intrahepatic or extrahepatic depending on their anatomic location. The majority of p …
Update on the management of cholangiocarcinoma.
Skipworth JR, Keane MG, Pereira SP. Skipworth JR, et al. Dig Dis. 2014;32(5):570-8. doi: 10.1159/000360507. Epub 2014 Jul 14. Dig Dis. 2014. PMID: 25034290 Free PMC article. Review.
Cholangiocarcinoma (CC) is a rare cancer arising from the epithelium of the biliary tree, anywhere from the small peripheral hepatic ducts to the distal common bile duct. Classification systems for CC typically group tumours by anatomical location into intrah …
Cholangiocarcinoma (CC) is a rare cancer arising from the epithelium of the biliary tree, anywhere from the small peripheral hepatic duct
2,186 results